7150 Clearvista Dr, Indianapolis, IN, 46256 · (317) 621-5335
Beds
340
FY 2025
Star rating
3 of 5
Patient survey: 3 of 5
Net patient revenue
$619.7M
FY 2025
Net income
$87.0M
Patient care margin 13.3%
Discharges
18,046
Occupancy 75.5%
Clinicians
1,000
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $619.7M | $537.0M | 13.3% | $87.0M | 18,046 | $14.4M | 17.2% | 7.0% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate for COPD patients | 10% | US median 8.5% |
| Death rate for heart failure patients | 14.5% | US median 11% |
| Hospital-wide death rate within 30 days | 3.7% | US median 3.9% |
| Death rate for pneumonia patients | 17% | US median 15.2% |
| Death rate for stroke patients | 12% | US median 11.6% |
| Readmission rate for COPD | 21.1% |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2024 | $615.6M | $524.0M | 14.9% | $95.5M | 17,876 | $11.4M | 16.6% | 7.2% |
| 2023 | $581.9M | $483.8M | 16.9% | $101.7M | 17,548 | $11.3M | 19.4% | 7.3% |
| 2022 | $565.2M | $497.6M | 12.0% | $83.4M | 17,007 | $9.5M | 18.5% | 7.1% |
| 2021 | $547.0M | $431.9M | 21.0% | $119.3M | 16,839 | $8.6M | 19.0% | 8.3% |
| 2020 | $466.4M | $438.3M | 6.0% | $128.7M | 15,959 | $14.2M | 21.0% | 8.0% |
| US median 19.8% |
| Readmission rate for heart failure | 20.6% | US median 21.3% |
| Readmission rate after hip or knee replacement | 6.4% | US median 5.8% |
| Readmission rate for pneumonia | 16.5% | US median 17.2% |
| Complications after hip or knee replacement | 3.5% | US median 4.1% |
| Serious complications (patient safety composite) | 1.30 | US median 0.96 |
| C. diff intestinal infections (ratio to expected) | 0.29 | US median 0.28 · better |
| Central line bloodstream infections (ratio to expected) | 0.65 | US median 0.48 |
| Surgical site infections after colon surgery (ratio to expected) | 0.36 | US median 0.72 · better |
| Surgical site infections after hysterectomy (ratio to expected) | 0.74 | US median 0.81 |
| MRSA bloodstream infections (ratio to expected) | 0.59 | US median 0.60 |
| Catheter urinary tract infections (ratio to expected) | 0.39 | US median 0.40 · better |
| Doctors always communicated well | 78% | US median 79% |
| Nurses always communicated well | 75% | US median 80% |
| Patient survey summary star rating | 3 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 51% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 73% | US median 72% |
| Room and bathroom always clean | 58% | US median 73% |
| Patients who would definitely recommend the hospital | 72% | US median 71% |
| Patients who left the emergency department before being seen | 4% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 221 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 11% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 17% | US median 65% |
| Healthcare workers given the flu vaccine | 94% | US median 79% |
| 75 |
| $35,907.80 |
| $6,606.71 |
| $7,294.77 |
| DRG 177 RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MCC | 73 | $45,868.29 | $10,946.74 | $12,667.88 |
| DRG 189 PULMONARY EDEMA AND RESPIRATORY FAILURE | 69 | $54,577.51 | $8,979.55 | $9,973.97 |
| DRG 690 KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC | 67 | $28,513.07 | $5,015.13 | $5,985.69 |
| DRG 683 RENAL FAILURE WITH CC | 61 | $30,909.62 | $5,938.34 | $6,629.69 |
| DRG 689 KIDNEY AND URINARY TRACT INFECTIONS WITH MCC | 55 | $34,100.20 | $7,759.15 | $8,838.11 |
| DRG 065 INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH CC OR TPA IN 24 HOURS | 50 | $35,182.58 | $6,302.12 | $7,474.08 |
| DRG 193 SIMPLE PNEUMONIA AND PLEURISY WITH MCC | 50 | $48,252.94 | $8,881.86 | $9,867.73 |
| DRG 194 SIMPLE PNEUMONIA AND PLEURISY WITH CC | 43 | $29,291.09 | $5,362.26 | $5,880.23 |
| DRG 377 GASTROINTESTINAL HEMORRHAGE WITH MCC | 42 | $57,562.52 | $12,710.10 | $14,301.50 |
| DRG 330 MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH CC | 42 | $90,441.90 | $15,470.40 | $18,026.21 |
| DRG 392 ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MCC | 41 | $28,608.22 | $4,933.34 | $5,662.18 |
| DRG 641 MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITHOUT MCC | 41 | $27,072.46 | $5,128.66 | $5,829.71 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5302 Level 2 Upper GI Procedures | 242 | 218 | $1,333.93 | $1,444.50 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 226 | 199 | $1,163.98 | $1,219.56 |
| APC 8011 Comprehensive Observation Services | 167 | 161 | $1,945.11 | $2,090.36 |
| APC 5115 Level 5 Musculoskeletal Procedures | 141 | 138 | $10,026.41 | $10,771.69 |
| APC 5362 Level 2 Laparoscopy and Related Services | 125 | 125 | $7,374.79 | $8,164.45 |
| APC 5073 Level 3 Excision/ Biopsy/ Incision and Drainage | 125 | 117 | $2,010.06 | $2,141.49 |
| APC 5361 Level 1 Laparoscopy and Related Services | 82 | 81 | $4,051.08 | $4,357.80 |
| APC 5154 Level 4 Airway Endoscopy | 69 | 63 | $2,655.91 | $2,832.62 |
| APC 5116 Level 6 Musculoskeletal Procedures | 59 | 57 | $15,164.91 | $15,762.73 |
| APC 5114 Level 4 Musculoskeletal Procedures | 48 | 47 | $5,041.15 | $5,338.75 |
| APC 5183 Level 3 Vascular Procedures | 44 | 43 | $2,293.87 | $2,405.01 |
| APC 5165 Level 5 ENT Procedures | 38 | 38 | $4,103.48 | $4,436.36 |
Reported payments to this teaching hospital
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Community Hospital North is a nonprofit short-term acute care hospital in Indianapolis, IN with 340 beds, part of Community Health Network and a 3-star overall rating.
Community Hospital North in Indianapolis, IN has 340 beds (fiscal year 2025 cost report); 298 beds are certified for Medicare. It discharged 18,046 inpatients that year, with 75.5% of its beds in use on average.
In fiscal year 2025 (ending 2025-12-31), Community Hospital North reported net patient revenue of $619.7M and operating expenses of $537.0M, a margin on patient care of 13.3%. After other income and expenses its net income was $87.0M (13.9% of revenue), so it made a profit that year.
Community Hospital North is part of Community Health Network, a health system with 7 hospitals based in Indianapolis, IN. It is a nonprofit hospital.
Community Hospital North has an overall rating of 3 out of 5 stars in the official hospital quality ratings. Patients rate it 3 out of 5 stars in the patient survey.
Yes, Community Hospital North provides emergency services.
1,000 Medicare clinicians list Community Hospital North as a hospital they work at, most often in Nurse Practitioner, Family Practice, Physician Assistant.
In 2024, Community Hospital North had 1,977 Medicare inpatient stays in 71 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 114 stays; Medicare paid $13,275.07 per stay on average, compared with $15,524.21 across all hospitals.
In 2025, companies reported $9,838 in payments to Community Hospital North as a teaching hospital ($9,838 general and - for research) from 4 companies.